Skip to content

The therapeutic effect evaluation of the diagnosis and treatment mode of metabolic syndrome by the combination of interactive comprehensive management and Traditional Chinese medicine

The therapeutic effect evaluation of the diagnosis and treatment mode of metabolic syndrome by the combination of interactive comprehensive management and Traditional Chinese medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035641
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. sign the informed consent 2. Aged 40 to 70 years old; 3. New diagnosis of MS, or previous diagnosis of MS, poor control of hypoglycemic, hypotensive, lipid-lowering drugs, or obesity.BMI<=35, blood glucose <16,7mmol/L, HbA1c < 9%, systolic blood pressure < 180mmHg, diastolic blood pressure < 110mmHg. In line with the standard of TCM syndrome diagnosis

Exclusion criteria

Exclusion criteria: 1. Type I diabetes, diabetic ketoacidosis, ketoacidosis and seriously infected persons; 2. Allergic constitution; 3. Women who are pregnant or preparing to be pregnant or breast-feeding; 4. Recent operation, infection, myocardial infarction and other stress states; 5. Patients with serious heart, liver, kidney, brain, blood system complications or other serious primary diseases, psychiatric patients (ALT, BUN, Cr increased by more than 1.5 times); 6. Those who did not agree with the author (who could not cooperate with the diet control, or did not take the medicine according to the regulation, which affected the curative effect).

Design outcomes

Primary

MeasureTime frame
Fasting/postprandial blood glucose;Hba1c;Fasting lipid profile;endothelial injury marker;flow-mediated dilation;

Countries

China

Contacts

Public ContactHao Lu

Shuguang Hospital Affiliated to Shanghai Traditional Chinese Medicine

luaho403@126.com+86 18017091728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026